Status:

UNKNOWN

e-GOLIAH in Autistic Spectrum Disorders

Lead Sponsor:

Assistance Publique - Hôpitaux de Paris

Collaborating Sponsors:

University Hospital, Montpellier

Conditions:

Autism Spectrum Disorder

Eligibility:

All Genders

3-6 years

Phase:

NA

Brief Summary

Randomized open-label study comparing children aged 3 to 6 years with autism and normal cognitive development or mild cognitive impairment receiving the usual treatment plus intensive use of eGOLIAH (...

Detailed Description

In a context of increasing prevalence of Autism Spectrum Disorder (ASD) and the heterogeneity of children's profiles and abilities, early diagnosis is crucial in order to implement intensive, individu...

Eligibility Criteria

Inclusion

  • Inclusion criteria :
  • Child with autism confirmed by a validated instrument (ADI-R or ADOS)
  • Aged 3 to 6 years;
  • Parent(s) agree to get involved in the constraint of using the SG 5 times / week at home for 2 periods of 3 months.
  • Signature of the informed consent form by the 2 holders of parental authority or the only holder of parental authority present
  • Affiliation to a social security scheme (except AME)
  • Non-inclusion criteria :
  • Children with behavioral problems;
  • Unstabilized comorbid organic pathology;
  • Moderate and severe cognitive deficit (Intellectual Quotient less than 55);
  • Multi or polyhandicap.
  • Medication that may cause visual or cognitive impairment (PSAs, neuroleptics, etc.) or that may interfere with the study assessments
  • Degenerative diseases or any other disease that could interfere with the evaluations planned during this study (known epilepsy and/or history of seizures, etc.)
  • Photosensitive persons in order to avoid situations that could induce epileptic seizures in them

Exclusion

    Key Trial Info

    Start Date :

    June 15 2022

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ESTIMATED

    End Date :

    December 15 2024

    Estimated Enrollment :

    150 Patients enrolled

    Trial Details

    Trial ID

    NCT05271955

    Start Date

    June 15 2022

    End Date

    December 15 2024

    Last Update

    April 25 2022

    Active Locations (12)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 3 (12 locations)

    1

    Fondation Lenval - Hôpitaux Pédiatriques de Nice- CHU Lenval

    Nice, Alpes Maritimes, France, 06200

    2

    Centre Hospitalier Universitaire de Strasbourg

    Strasbourg, Bas-Rhin, France, 67091

    3

    Centre Hospitalier Universitaire de Toulouse

    Toulouse, Haut-Garonne, France, 31059

    4

    Centre Hospitalier Universitaire de Montpellier

    Montpellier, Hérault, France, 34295

    e-GOLIAH in Autistic Spectrum Disorders | DecenTrialz